Clinical Trial Update: FES BPET-DBT in Newly Diagnosed Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial at Abramson Cancer Center is evaluating FES BPET-DBT imaging in newly diagnosed breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | EARLY_Phase 1 | Status: RECRUITING